Identification of a T2-hyperintense Perivascular Space in Brain Arteriovenous Malformations
The identification of T2-hypertinense perivascular spaces surrounding brain AVMs on neuroradiological imaging may provide insights into the anatomico-radiological relationships of brain AVMs and the surrounding grey and white matter parenchyma. These findings could have future implications for our understanding of brain AVM biology and may influence neurosurgical approaches to these lesions.
Authors
- Thomas Wälchli (ORCID: https://orcid.org/0000-0002-8961-6551)
- Patrick Joseph Nicholson
- Will Guest (ORCID: https://orcid.org/0000-0003-0836-3669)
- Philippe P. Monnier (ORCID: https://orcid.org/0000-0002-6221-4130)
- Jeroen Bisschop (ORCID: https://orcid.org/0000-0001-8652-9535)
- IVAN RADOVANOVIC
- Hans Kortman (ORCID: https://orcid.org/0000-0002-4183-7881)
- Kartik Bhatia (ORCID: https://orcid.org/0000-0002-3431-5647)
- Paul E. Constanthin (ORCID: https://orcid.org/0000-0003-1914-8876)
- Timo Krings (ORCID: https://orcid.org/0000-0001-6321-5787)
- Ethan A. Winkler (ORCID: https://orcid.org/0000-0002-7908-7107)
- Aristotelis Kalyvas (ORCID: https://orcid.org/0000-0002-0222-488X)
- Moncef Berhouma (ORCID: https://orcid.org/0000-0003-1852-071X)
- Leonardo Olijnyk
Institutions
- University Health Network (CA)
- University of California, San Francisco (US)
- University of Toronto (CA)
- National and Kapodistrian University of Athens (GR)
- Toronto Western Hospital (CA)
- Beaumont Hospital (IE)
- Hôpital Beau-Séjour (CH)
- University Hospital of Zurich (CH)
- University General Hospital Attikon (GR)
- Sydney Children’s Hospitals Network (AU)
- Elisabeth-TweeSteden Ziekenhuis (NL)
- Neurological Surgery (US)
- Krembil Research Institute
Publication Details
- Journal
- In Vivo
- Published
- 2024-12-31
- DOI
- https://doi.org/10.21873/invivo.13826
- Citations
- 2
- Primary Topic
- Vascular Malformations Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.74
Funders
- Novartis Foundation
- Hope Foundation
- Novartis Stiftung für Medizinisch-Biologische Forschung
- Universität Zürich
- EMDO Stiftung
- Swiss Cancer Research Foundation